Status: Recruiting
Novel Targets for the Development of Monoclonal Antibodies for Immunotherapy)
The first objective of the project consists in the preclinical validation of new possible molecular targets associated with intratumoral T regulatory cells. The second objective consists in the selection of monoclonal antibodies with therapeutic potential, specific for the selected targets.
Participants needed: 600
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Checkmab S.r.l.Updated: Feb 24, 2025Locations: 1
Eligibility criteria
blood donors [+2]
age below 18 years [+3]